Download
s13023-020-01548-9.pdf 1,08MB
WeightNameValue
1000 Titel
  • Challenging behavior in mucopolysaccharidoses types I–III and day-to-day coping strategies: a cross sectional explorative study
1000 Autor/in
  1. Hoffmann, Frederik |
  2. Hoffmann, Susanne |
  3. Kunzmann, Kevin |
  4. Ries, Markus |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-02
1000 Erschienen in
1000 Quellenangabe
  • 15(1):275
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13023-020-01548-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532084/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Challenging behavior represents a core symptom in neuropathological mucopolysaccharidoses (MPS) and puts major strain on affected families. Although multimodal approaches including behavioral strategies to treatment could be valuable, there is lack of research to the effectiveness of specific measures. This explorative, cross-sectional study is aimed at the collection of parental experiences regarding effective day-to-day measures against challenging behavior in MPS and focuses on 4 major research questions: First: What is challenging behavior in MPS? Second: Which strategies are helpful in the day-to-day coping with challenging behavior? Third: How strong is parental acceptance of illness and the disorder's impact on family relationships? Fourth: What are beneficial personal and interfamilial strategies for generally coping with the disorder?!##!Methods!#!A semi structured questionnaire was designed de novo in cooperation with affected families. 37/268 questionnaires were returned (rate: 13.8%), of which 34 (MPS I: n = 8, MPS II: n = 8; MPS III: n = 18) could be included in data analysis in accordance with inclusion criteria. Assessment of challenging symptoms was based on perceived frequency, parent- and child stress. Exploration of possible coping strategies for challenging behavior and general illness-related strain included the evaluation of perceived effectiveness. Questionnaires were completed by patient's relatives and analyzed for strategies to cope with challenging behavior and the disorder's impact. STROBE criteria were respected.!##!Results!#!MPS I was reported to show lower frequency and better perceived manageability of challenging behavior than MPS II and -III. Sleep disturbance, hyperactivity, agitation, aggression and orality seemed relevant symptoms regarding frequency and/or parent stress. Reported measures were manifold, worthwhile approaches against challenging behavior appeared to be aiming at distraction, relief and environmental changes. Medication and non-medication approaches were rated similarly effective. Social exchange, private space and networking with other affected families seemed highly important for personal and interfamilial well-being.!##!Conclusions!#!Multimodal mentoring for affected families could be based on the following equivalent pillars: (1) Medication therapy for challenging behavior including evaluation of cost and benefit (2) Guided implementation and re-evaluation of specific behavioral measures against challenging behavior. (3) Psychosocial support of MPS-families, including options for strengthening parental well-being and family functioning. Trial registration This study was registered at clinicaltrials.gov prior to study start (NCT-Number: NCT03161171, Date: 2017/05/19).
1000 Sacherschließung
lokal Mucopolysaccharidosis I [MeSH]
lokal Coping
lokal Day-to-day coping
lokal MPS
lokal Humans [MeSH]
lokal Lysosomal storage diseases
lokal Mucopolysaccharidosis III [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Hunter
lokal Hurler
lokal Mucopolysaccharidoses [MeSH]
lokal Sanfilippo
lokal Adaptation, Psychological [MeSH]
lokal Original Research
lokal Challenging behavior
lokal Mucopolysaccharidoses
lokal Child [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-1756-6185|https://frl.publisso.de/adhoc/uri/SG9mZm1hbm4sIFN1c2FubmU=|https://frl.publisso.de/adhoc/uri/S3Vuem1hbm4sIEtldmlu|https://frl.publisso.de/adhoc/uri/UmllcywgTWFya3Vz
1000 Hinweis
  • DeepGreen-ID: 706f3b5ed57a4ef080d281b2b92f2629 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463025.rdf
1000 Erstellt am 2023-11-15T16:06:01.543+0100
1000 Erstellt von 322
1000 beschreibt frl:6463025
1000 Zuletzt bearbeitet Thu Nov 30 20:52:57 CET 2023
1000 Objekt bearb. Thu Nov 30 20:52:57 CET 2023
1000 Vgl. frl:6463025
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463025 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source